C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2002
11/05/2002	US6475725 Recombinant cell clones having increased stability and methods of making and using the same
11/05/2002	US6475724 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
11/05/2002	US6475723 Pathogenic tau mutations
11/05/2002	US6475718 Genetically engineered eukaryotic cell; for prevention of viral infections; viricides
11/05/2002	US6475487 Treatment of a patient by administering an antibody that inhibits cathepsin O
11/05/2002	US6475485 Two novel human cathepsin proteins
11/05/2002	US6475483 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens for treating autoimmune diseases
11/05/2002	US6475481 Purging of stem cell products
11/05/2002	US6475480 Use of adenoviral E4 reading frames to improve expression of a gene of interest
11/05/2002	EP1185211A4 Bioengineered anterior cruciate ligament
11/05/2002	EP0792098A4 Enhancing growth and pearl production in mollusks
11/05/2002	CA2234396C Method for production of native human leukocyte (alpha) interferon
11/05/2002	CA2147124C Erythropoietin analogs
11/05/2002	CA2069437C Process for control of fruit ripening in plants
11/05/2002	CA2066777C Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection
11/05/2002	CA2011833C Novel polypeptide and production thereof
11/04/2002	EP1163324A4 Genetically modified plants having modulated brassinosteroid signaling
11/03/2002	CA2384605A1 Granule-bound starch synthase
10/2002
10/31/2002	WO2002086510A1 Method and composition for skin grafts
10/31/2002	WO2002086443A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086152A1 Non-recombinant cell lines capable of expressing predominantly cyclic nucleotide phophodiesterase 4 (pde4) subtype b and their use for the screening of pde4 subtype-specific modulators
10/31/2002	WO2002086144A2 Compositions and methods for recombinational cloning of nucleic acid molecules
10/31/2002	WO2002086133A1 Medium additives and media for culturing animal cells
10/31/2002	WO2002086125A2 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour
10/31/2002	WO2002086123A2 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/31/2002	WO2002086121A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides
10/31/2002	WO2002086119A1 Transformed silkworm producing human collagen
10/31/2002	WO2002086114A1 Lipoxygenase
10/31/2002	WO2002086113A2 Enzyme and snp marker for disease
10/31/2002	WO2002086112A2 Nucleic acid molecules encoding starch degrading enzymes
10/31/2002	WO2002086108A1 Method for differentiating mesenchymal stem cells into neural cells
10/31/2002	WO2002086107A2 A method for differentiating stem cells into insulin-producing cells
10/31/2002	WO2002086106A1 Method and culture medium for producing neural cells expressing tyrosine hydroxylase
10/31/2002	WO2002086104A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
10/31/2002	WO2002086103A1 A method of nuclear transfer
10/31/2002	WO2002086094A2 Genes involved in isoprenoid compound production
10/31/2002	WO2002086090A2 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002	WO2002086087A2 Cytokine protein family
10/31/2002	WO2002086085A2 Human timp-1 antibodies
10/31/2002	WO2002086083A2 Methods of enhancing cell responsiveness
10/31/2002	WO2002086082A2 Isolation of neural stem cells using gangliosides and other surface markers
10/31/2002	WO2002086079A2 T1r3 a novel taste receptor
10/31/2002	WO2002086075A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs
10/31/2002	WO2002086073A2 Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002086068A2 Methods for producing recombinant coronavirus
10/31/2002	WO2002085945A2 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002	WO2002085944A2 Single chain camelid vhh antibodies, method for their production in a mammal and their uses
10/31/2002	WO2002085943A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085936A1 Mutants of green fluorescent protein
10/31/2002	WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002	WO2002085923A2 In vivo incorporation of unnatural amino acids
10/31/2002	WO2002085419A2 Bifunctional-modified hydrogels
10/31/2002	WO2002085337A1 Micellar drug delivery systems for hydrophobic drugs
10/31/2002	WO2002085306A2 Use of follistatin to increase muscle mass
10/31/2002	WO2002085305A2 Compositions and methods for inducing cancer cell death
10/31/2002	WO2002085300A2 Methods of using interleukin-7 to modulate physiological processes in mammalian pulmonary fibroblasts
10/31/2002	WO2002085297A2 Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
10/31/2002	WO2002085286A2 Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals
10/31/2002	WO2002085285A2 Methods and reagents for regulating bone and cartilage formation
10/31/2002	WO2002085116A1 Sprr1a and axonal regeneration
10/31/2002	WO2002085110A1 Egg freezing preservation tool, and cylindrical member holding tool
10/31/2002	WO2002070737A8 Compositions and methods relating to osteoarthritis
10/31/2002	WO2002070565A9 High-affinity antagonists of elr-cxc chemokines
10/31/2002	WO2002068585A3 Tip39 polypeptides
10/31/2002	WO2002066681A9 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
10/31/2002	WO2002066650A3 Streptococcus pyogenes polypeptides and corresponding dna fragments
10/31/2002	WO2002062961A9 Peptide scaffold encapsulation of tissue cells and uses thereof
10/31/2002	WO2002061105A9 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
10/31/2002	WO2002061048A3 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses
10/31/2002	WO2002060477A9 Scaffolded fusion polypeptides, compositions for making the same and methods of using the same
10/31/2002	WO2002055680A3 Morphometric tissue or cell preparation
10/31/2002	WO2002055547A9 Sfrp and peptide motifs that interact with sfrp and methods of their use
10/31/2002	WO2002046365A3 Method and apparatus to grow and mechanically condition cell cultures
10/31/2002	WO2002042455A3 Modifier of organelle metalbolism
10/31/2002	WO2002034913A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/31/2002	WO2002031137A3 Cytomegalovirus intron a fragments
10/31/2002	WO2002029075A3 Multiple inducible gene regulation system
10/31/2002	WO2002024912A3 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
10/31/2002	WO2002018560A3 Butinol i esterase
10/31/2002	WO2002016566A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/31/2002	WO2002014499A3 Claudin polypeptides
10/31/2002	WO2002012502A3 Anti-tnf antibodies, compositions, methods and uses
10/31/2002	WO2002010392A3 Mammalian dna binding membrane-associated protein-encoding gene and uses
10/31/2002	WO2002000262A3 Modulation of chromosome function by chromatin remodeling agents
10/31/2002	WO2001098343A3 Conserved diaphanous-related formin autoregulatory domain (dad)
10/31/2002	WO2001075067A9 Novel nucleic acids and polypeptides
10/31/2002	WO2001061356A9 Her-2 binding antagonists
10/31/2002	WO2001059152A3 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
10/31/2002	WO2001055432A3 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
10/31/2002	WO2001051633A9 Compositions and methods for the therapy and diagnosis of prostate cancer
10/31/2002	US20020162138 Transgenic plants and plant cells, in which an amylopectin with an altered degree of branching is synthesized
10/31/2002	US20020162137 Materials and methods for the alteration of enzyme and acetyl coa levels in plants
10/31/2002	US20020162134 Primordial germ cell-based germ line production of birds
10/31/2002	US20020162132 Useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions
10/31/2002	US20020162130 Transgenic mouse expressing the human cyclooxygenase-2 gene and neuronal cell cultures derived therefrom
10/31/2002	US20020162129 Prevention and treatment of alzheimer's disease
10/31/2002	US20020162126 Methods and compositions for RNA interference

1 ... 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 ... 1827